Showing results (41-50 of 310) with videos related to
Sort By:
Pageof 31
Current Opinion in Rheumatology|August 28, 2024
Treatment of interstitial lung disease in systemic sclerosis: guidelines and new clinical trial resultsSindhu R Johnson, Elana J BernsteinBest Practice & Research. Clinical Rheumatology|April 16, 2026
Screening, monitoring and treatment of interstitial lung disease in systemic sclerosisSindhu R Johnson, Elana J BernsteinJournal of Scleroderma and Related Disorders|April 6, 2022
Systemic sclerosis phase III clinical trials: Hope on the horizon?Martin Aringer, Christopher P DentonExpert Opinion on Drug Safety|December 9, 2014
Safety of off-label biologicals in systemic lupus erythematosusMartin Aringer, Josef S SmolenRheumatic Diseases Clinics of North America|July 27, 2015
New Classification Criteria for Systemic Sclerosis (Scleroderma)Janet E Pope, Sindhu R JohnsonClinical and Experimental Rheumatology|October 17, 2013
Withdrawal of therapy in non-renal systemic lupus erythematosus: is this an achievable goal?Marta Mosca, Chiara Tani, Martin AringerRheumatic Diseases Clinics of North America|October 1, 2019
Treat to Target in Systemic Lupus ErythematosusMartin Aringer, Nicolai Leuchten, Matthias SchneiderAnnals of the New York Academy of Sciences|July 25, 2012
Role of interleukin-6 in stress, sleep, and fatigueNicolas Rohleder, Martin Aringer, Matthias BoentertRheumatology (Oxford, England)|September 6, 2021
Glucocorticoid dosing and relapses in giant cell arteritis-a single centre cohort studyLaura Felten, Nicolai Leuchten, Martin AringerThe Journal of Rheumatology|November 3, 2010
Biologic therapy for systemic sclerosis: a systematic reviewVeerapong Phumethum, Shahin Jamal, Sindhu R JohnsonPageof 31